Biotech Stock News (GWPH)(CPXX)(VTAE)

GW Pharmaceuticals (NASDAQ:GWPH) On March 14, 2016 shares of GW Pharmaceutical were up 124% after the company announced that it had obtained positive phase 3 results for its drug, known as Epidiolex. The drug was able to meet the primary endpoint of the study, which was a reduction of seizures compared to the placebo. The … Read more

Tuesday Talk: Biotech News 2/23/15 to 2/27/15

Valeant Pharmaceuticals (VRX) & Salix Pharmaceuticals (SLXP) Valeant Pharmaceuticals had agreed to buy Salix Pharmaceuticals for about $10.4 billion dollars in an all cash type deal. Valeant currently has many approved drugs in various areas such as: skin, eyes, and oral type drugs. This addition of Salix Pharmaceuticals will give Valeant access to a gastrointestinal … Read more